In human studies insulin resistance is closely associated with the advanced stage of liver fibrosis in NASH patients, and the fibrosis is partially reversed by treatment with insulin sensitizers, such as pioglitazone, rosiglitazone and metformin ([69,75,76,77], reviewed in [72,73,74]). The gene discussed is INS; the disease is metabolic dysfunction-associated steatohepatitis.